Compare RYAM & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAM | VALN |
|---|---|---|
| Founded | 1926 | 2012 |
| Country | United States | France |
| Employees | 2325 | N/A |
| Industry | Paper | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 661.8M | 536.9M |
| IPO Year | 2014 | 2021 |
| Metric | RYAM | VALN |
|---|---|---|
| Price | $8.73 | $5.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $14.00 | ★ $15.50 |
| AVG Volume (30 Days) | ★ 907.6K | 47.7K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,466,397,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.22 | $93.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.35 | $5.06 |
| 52 Week High | $11.85 | $12.25 |
| Indicator | RYAM | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 49.54 |
| Support Level | $8.15 | $5.81 |
| Resistance Level | $8.80 | $6.53 |
| Average True Range (ATR) | 0.44 | 0.25 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 23.37 | 49.31 |
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.